In recent times,
Celanese Co. (NYSE:CE) has drawn notable investor attention, including that of
Hsbc Holdings PLC and
Dimensional Fund Advisors LP that have been amassing their holdings while other stakeholders, like
Seven Eight Capital LP and
Caprock Group LLC, have been increasing theirs. The recent growth rank stands at
8 as of September 2024, with an impressive ROE of 25%. Concerns have been raised regarding the company's leverage risks, despite consistent margin expansion. The company's stock performance has shown some inconsistency, fluctuating between underperforming and outperforming competitors. The organization's Q2 2024 earnings, which showcased a miss on EPS estimates and a decrease in sales, have impacted the stock adversely, leading to a drop of over 5% after a forecasted slash in 2024 earnings. Supply chain disruptions led to the declaration of force majeure, adding to the challenges for the corporation. Despite these difficulties, the company's robust cash flow and deleveraging were achievements of note. Despite the underperformance, the stock continues to have bullish and bearish predictions with some considering it potentially undervalued. The company has been strategic with board appointments and making significant strides in the acetyl chain business.
Celanese Corporation CE News Analytics from Sat, 03 Oct 2020 17:02:25 GMT to Sun, 22 Sep 2024 11:04:14 GMT -
Rating 0
- Innovation -4
- Information 6
- Rumor 4
